Risk Management as a Core Philosophy
Why quality by design is not optional, but essential for maintaining compliance, avoiding delays, and ensuring inspection readiness in clinical development.
ICH E8(R1) and ICH E6(R3) have fundamentally shifted the regulatory landscape. The days of retroactive quality assurance—waiting for the monitor to catch errors during source data verification—are over. Today, regulatory bodies expect Quality by Design (QbD).
Embedding Quality from Day One
Risk management must be a core philosophy embedded in the protocol development phase. If a protocol is overly complex, requires unnecessary procedures, or sets unrealistic timelines, non-compliance is almost guaranteed. By integrating risk assessment into the foundational design of the trial, sponsors can identify Critical to Quality (CtQ) factors and allocate resources where they matter most: protecting subject safety and the reliability of trial results.
Sponsors who embrace RBQM (Risk-Based Quality Management) not only reduce their regulatory exposure but also achieve significant operational efficiencies, faster database locks, and a much smoother path through BIMO inspections.
End of File
Return to Top arrow_upward